Trial intelligence / Profile preview

Remimazolam vs propofol for colonoscopy sedation

CTR20171411Phase 2Completed

Sponsor
Yichang Humanwell Pharmaceutical Co., Ltd.
Start
Sep 2018
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of remimazolam in procedural sedation and analgesia (PSA), sponsored by Yichang Humanwell Pharmaceutical Co., Ltd.. Started Sep 2018; status: completed.

02

Drugs

remimazolam
03

Conditions

procedural sedation and analgesia (PSA)

Beyond the preview

Go deeper on CTR20171411.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on CTR20171411.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call